Tarsons Products Stock Screener | Share Price & Fundamental Analysis
TARSONS
Medical Equipment
Screen Tarsons Products share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹230.51
▼
-4.74 (-2.01%)
Share Price BSE
₹230.25
▼
-4.85 (-2.06%)
Market Cap
₹1,227.89 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.99
EPS (TTM)
₹5.60
Dividend Yield
-
Debt to Equity
0.49
52W High
₹442.55
52W Low
₹199.85
Operating Margin
33.00%
Profit Margin
8.55%
Revenue (TTM)
₹117.00
EBITDA
₹41.00
Net Income
₹10.00
Total Assets
₹1,080.00
Total Equity
₹630.00
Tarsons Products Share Price History - Stock Screener Chart
Screen TARSONS historical share price movements with interactive charts. Analyze price trends and patterns.
Tarsons Products Company Profile - Fundamental Screener
Screen Tarsons Products company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TARSONS shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE144Z01023
Tarsons Products Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen TARSONS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2022 | 2021 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 1,080 | 972 | 544 | 296 |
| Current Assets | 243 | 235 | 245 | 113 |
| Fixed Assets | 536 | 336 | 189 | 120 |
| Liabilities | ||||
| Total Liabilities | 1,080 | 972 | 544 | 296 |
| Current Liabilities | 274 | 146 | 20 | 10 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 630 | 613 | 490 | 244 |
| Share Capital | 11 | 11 | 11 | 0 |
| Reserves & Surplus | 620 | 602 | 479 | 244 |
Screen TARSONS income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Dec | 2022-Mar | 2021-Mar | 2021-Jun | 2021-Sept | 2021-Dec | 2020-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117 | 95 | 108 | 109 | 88 | 108 | 97 | 65 | 88 | 68 | 71 | 77 | 73 | 62 |
| Expenses | 76 | 67 | 75 | 76 | 66 | 74 | 66 | 39 | 41 | 33 | 32 | 38 | 38 | 30 |
| EBITDA | 41 | 28 | 33 | 34 | 22 | 34 | 31 | 26 | 47 | 36 | 39 | 40 | 36 | 32 |
| Operating Profit % | 33.00% | 27.00% | 27.00% | 29.00% | 22.00% | 26.00% | 31.00% | 37.00% | 52.00% | 52.00% | 53.00% | 50.00% | 47.00% | 51.00% |
| Depreciation | 20 | 20 | 23 | 12 | 11 | 14 | 17 | 10 | 7 | 3 | 5 | 5 | 5 | 4 |
| Interest | 5 | 5 | 5 | 4 | 4 | 5 | 5 | 3 | 0 | 1 | 1 | 2 | 1 | 1 |
| Profit Before Tax | 16 | 3 | 6 | 17 | 6 | 15 | 8 | 14 | 39 | 32 | 33 | 34 | 29 | 28 |
| Tax | 5 | 1 | 2 | 7 | 2 | 5 | 3 | 4 | 10 | 8 | 9 | 9 | 7 | 7 |
| Net Profit | 10 | 2 | 3 | 10 | 4 | 10 | 5 | 10 | 30 | 24 | 25 | 25 | 22 | 21 |
| EPS | 1.92 | 0.34 | 0.62 | 1.94 | 0.75 | 1.93 | 0.99 | 1.87 | 5.69 | 4.59 | 4.88 | 4.89 | 4.14 | 4.13 |
Tarsons Products Cash Flow Screener - Liquidity Fundamentals
Screen TARSONS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2022-March | 2021-March |
|---|---|---|---|---|
| Operating Activities | 114 | 103 | 84 | 68 |
| Investing Activities | -145 | -285 | -138 | -64 |
| Financing Activities | 39 | 136 | 130 | -27 |
| Net Cash Flow | 8 | -47 | 75 | -23 |
Screen TARSONS shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 47.31% | 47.31% | 47.31% | 47.31% | 47.31% | 47.31% | 47.31% | 47.31% |
| FII Holding | 9.52% | 9.14% | 5.82% | 8.16% | 7.95% | 8.04% | 7.51% | 0.00% |
| DII Holding | 0.29% | 0.04% | 0.08% | 0.18% | 0.12% | 0.21% | 0.50% | 8.45% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.30% | 15.42% | 17.14% | 13.44% | 13.53% | 13.06% | 15.37% | 10.00% |
| Other Holding | 27.58% | 28.09% | 29.65% | 30.92% | 31.10% | 31.39% | 29.31% | 34.25% |
| Shareholder Count | 93,417 | 90,891 | 88,966 | 102,866 | 105,330 | 99,586 | 96,927 | 105,304 |
Tarsons Products Dividend Screener - Share Yield Analysis
Screen TARSONS dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹2.00 | 0.66% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Tarsons Products Index Membership - Market Screener Classification
Screen TARSONS by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Tarsons Products Market Events Screener - Corporate Actions
Screen TARSONS market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -17.14% | ||
| Annual General Meeting | NA | -2.81% | ||
| Dividend | ₹ 2.00 /share | 11.87% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -7.25% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.51% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 11.62% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.49% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 3.04% |
Tarsons Products Competitors Screener - Peer Comparison
Screen TARSONS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 17,801 | 49.92 | 1,759 | 22.62% | 339 | 31.37 |
| Laxmi Dental | 1,426 | 55.65 | 242 | 24.12% | 25 | 38.36 |
| Tarsons Products | 1,228 | 60.45 | 408 | 32.64% | 30 | 44.38 |
| Osel Devices | 1,032 | 52.70 | 187 | 40.62% | 20 | 41.15 |
| Vasa Denticity | 934 | 63.16 | 249 | 43.89% | 17 | 35.49 |
| Fabtech Technologies | 899 | 19.94 | 336 | 45.66% | 47 | 33.60 |
| Aprameya Engineering | 608 | 37.94 | 136 | 107.77% | 16 | 51.14 |
| Prevest Denpro | 580 | 29.90 | 67 | 13.15% | 18 | 53.15 |
| Hemant Surgical Industries | 389 | 49.35 | 112 | % | 8 | 54.68 |
| Vaidya Sane Ayurved Laboratories | 293 | 41.38 | 90 | -11.13% | 7 | 52.34 |
Tarsons Products Company Announcements - News Screener
Screen TARSONS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Closure of Trading Window | View |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-27 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Further Investment In Tarsons Life Science Pte. Ltd. A Wholly-Owned Subsidiary Of The Company. | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday November 12 2025 | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-04 | Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-22 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-18 | Reg. 34 (1) Annual Report. | View |
| 2025-08-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-30 | Business Responsibility and Sustainability Reporting (BRSR) | View |